Regeneron Pharmaceuticals (REGN.VI) Q3 2025 Earnings

1AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
7.22
8.69
10.16
11.64

Details

Expected EPS
7.2750287874
Actual EPS
11.122781
Surprise EPS
3.85
Surprise Percent
+52.89%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 11.122781 per share for Q3 2025.

0 Comments

Share your thoughts